Skip to main content
Year archive

ONCOSIL MEDICAL LTD — 2023 filings

All 69 regulatory filings released by ONCOSIL MEDICAL LTD (OSL) in 2023, sourced directly from the official regulator.

69 Filings
2023 Period
2023 filings (69)
Filing Released Lang
Change of Director's Interest Notice DC NL GL 9 pages 322.6KB
Director's Dealing
2023-12-19 English
Notification regarding unquoted securities - OSL 6 pages 28.4KB
Share Issue/Capital Change
2023-12-18 English
Notification regarding unquoted securities - OSL 7 pages 31.0KB
Share Issue/Capital Change
2023-12-18 English
Notification of cessation of securities - OSL 4 pages 23.9KB
Regulatory Filings
2023-12-17 English
Proposed issue of securities - OSL 5 pages 29.2KB
Capital/Financing Update
2023-12-17 English
OncoSil receives $1.1m R&D tax incentive 2 pages 169.8KB
Regulatory Filings
2023-12-14 English
First two commercial patient treatments in Greece 3 pages 280.2KB
Regulatory Filings
2023-12-07 English
Notification of cessation of securities - OSL 4 pages 23.9KB
Regulatory Filings
2023-12-05 English
Final Director's Interest Notice BL 2 pages 231.9KB
Director's Dealing
2023-12-04 English
OncoSil onboards first patient in PANCOSIL Clinical Trial 3 pages 241.2KB
Regulatory Filings
2023-11-28 English
Presentation to Annual General Meeting 31 pages 3.7MB
Investor Presentation
2023-11-28 English
Results of Annual General Meeting 2 pages 180.8KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-28 English
OncoSil gaining traction in the Israeli healthcare market 3 pages 218.9KB
Regulatory Filings
2023-11-23 English
Notice of Annual General Meeting/Proxy Form 43 pages 852.9KB
AGM Information
2023-10-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 446.6KB
Interim / Quarterly Report
2023-10-29 English
Date of AGM and Closing Date for Director Nominations 2 pages 178.7KB
AGM Information
2023-10-03 English
Mr Brian Leedman to retire from the Board of OncoSil 2 pages 181.7KB
Board/Management Information
2023-09-17 English
Notification of cessation of securities - OSL 4 pages 23.9KB
Share Issue/Capital Change
2023-09-12 English
Appendix 4E and Annual Report 76 pages 2.4MB
Annual Report
2023-08-30 English
Corporate Governance Statement 8 pages 216.4KB
Governance Information
2023-08-30 English
Appendix 4G 12 pages 356.2KB
Governance Information
2023-08-30 English
Otto Buttula retires and Douglas Cubbin appointed Chair 2 pages 262.3KB
Board/Management Information
2023-08-30 English
Final Director's Interest Notice OB 2 pages 196.9KB
Director's Dealing
2023-08-30 English
Change of principal place of business 2 pages 182.6KB
Regulatory Filings
2023-08-15 English
Initial Director's Interest Notice 2 pages 220.6KB
Director's Dealing
2023-08-09 English
Douglas Cubbin appointed as Incoming Chairman of OncoSil 2 pages 274.1KB
Board/Management Information
2023-08-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 449.6KB
Interim / Quarterly Report
2023-07-27 English
Initial Director's Interest Notice GL 2 pages 221.6KB
Director's Dealing
2023-07-17 English
Gabriel Liberatore appointed to the Board of OncoSil 2 pages 183.0KB
Board/Management Information
2023-07-13 English
Change of Directors Interest Notice - Appendix 3Y OB 3 pages 248.5KB
Director's Dealing
2023-07-03 English
Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer 3 pages 244.0KB
Regulatory Filings
2023-06-29 English
Notification of cessation of securities - OSL 5 pages 26.5KB
Regulatory Filings
2023-06-28 English
Ethics Committee Approves PANCOSIL Clinical Trial 3 pages 213.7KB
Regulatory Filings
2023-06-04 English
Change of CFO, Company Secretary and Registered Office 2 pages 214.2KB
Board/Management Information
2023-05-31 English
Mr Otto Buttula to Retire from the Board 2 pages 393.7KB
Board/Management Information
2023-05-23 English
Resignation of Chief Financial Officer 2 pages 210.4KB
Board/Management Information
2023-05-23 English
First patient treatment in Italy 3 pages 252.2KB
Regulatory Filings
2023-05-21 English
Notification of cessation of securities - OSL 4 pages 24.5KB
Share Issue/Capital Change
2023-05-11 English
Becoming a substantial holder 3 pages 2.5MB
Regulatory Filings
2023-05-11 English
Application for quotation of securities - OSL 7 pages 30.3KB
Capital/Financing Update
2023-05-10 English
Top 20 Holdings and Distribution Schedule of OSLO Options 7 pages 741.5KB
Major Shareholding Notification
2023-05-10 English
Change of Director's Interest Notice - Nigel Lange 3 pages 256.6KB
Director's Dealing
2023-05-10 English
Change of Director's Interest Notice - Brian Leedman 3 pages 262.9KB
Director's Dealing
2023-05-10 English
Entitlement Offer Results and Shortfall Notification 2 pages 218.9KB
Capital/Financing Update
2023-05-08 English
First patient enrolled in the TRIPP-FFX Clinical Study 3 pages 255.7KB
Regulatory Filings
2023-05-02 English
OncoSil to streamline operating structure 2 pages 222.2KB
Capital/Financing Update
2023-05-01 English
First year anniversary of the OSPREY post-marketing registry 2 pages 259.2KB
Regulatory Filings
2023-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 477.8KB
Interim / Quarterly Report
2023-04-27 English
Further commercial milestones achieved in Spain 3 pages 223.6KB
Capital/Financing Update
2023-04-23 English
Oral presentation at The Mayo Clinic IMPACT Course 2 pages 222.6KB
Investor Presentation
2023-04-23 English
Update - Proposed issue of securities - OSL 8 pages 36.2KB
Capital/Financing Update
2023-04-23 English
Late Lodgement of Change in Director's Interest Notice 4 pages 354.5KB
Director's Dealing
2023-04-23 English
Additional Binding Commitment Received for Entitlement Offer 2 pages 208.9KB
Capital/Financing Update
2023-04-20 English
Extension of Closing Date of Entitlement Offer 3 pages 211.0KB
Capital/Financing Update
2023-04-20 English
Entitlement Offer - Despatch of Documents 2 pages 206.0KB
Capital/Financing Update
2023-03-27 English
Letter to Ineligible Shareholders 2 pages 251.4KB
Capital/Financing Update
2023-03-27 English
Non-renounceable Rights Issue Offer Prospectus 50 pages 756.4KB
Capital/Financing Update
2023-03-19 English
Entitlement Offer to raise up to $9.9 million 6 pages 281.6KB
Capital/Financing Update
2023-03-16 English
Entitlement Offer Presentation 18 pages 948.5KB
Capital/Financing Update
2023-03-16 English
Proposed issue of securities - OSL 8 pages 36.7KB
Capital/Financing Update
2023-03-16 English
Commitment received for Offer and updated Timetable 2 pages 199.9KB
Capital/Financing Update
2023-03-16 English
Update - Proposed issue of securities - OSL 8 pages 36.3KB
Capital/Financing Update
2023-03-16 English
Cancellation of Unlisted Options and Loan Funded Shares 4 pages 208.1KB
Regulatory Filings
2023-03-05 English
Change of Director's Interest Notice 2 pages 229.5KB
Director's Dealing
2023-03-05 English
Final Director's Interest Notice 2 pages 198.5KB
Director's Dealing
2023-03-05 English
Half Yearly Report and Accounts 20 pages 653.3KB
Interim / Quarterly Report
2023-02-27 English
Half-Yearly Report Results 3 pages 276.3KB
Interim / Quarterly Report
2023-02-27 English
Two key treatment centres treat first patients with OncoSil 2 pages 193.1KB
Regulatory Filings
2023-01-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 463.8KB
Interim / Quarterly Report
2023-01-30 English